Overcoming Challenges in Clinical Data Review

This white paper discusses the challenges faced in clinical data review, which is essential for ensuring patient safety, determining drug efficacy, and assessing data quality during clinical development. It outlines the complexities involved in analyzing diverse clinical trial data and the necessity for integrating multiple data sources for effective analysis. Key challenges include the risk of missing safety signals, the inability of existing tools to be tailored for specific studies, and the difficulties in drawing relationships from data due to outdated practices. The paper presents five strategies to enhance clinical data review: speed, agility, customizable analytics, workflow flexibility, and collaboration. Additionally, it introduces Revvity Signals Clinical Analytics solutions, designed to facilitate self-service analytics, improve data review processes, and accelerate the delivery of therapeutics to patients. The white paper emphasizes the importance of addressing these challenges to enhance clinical research efficiency and ensure patient safety.